Chick-fil-A Modifies Antibiotic Policy Amid Supply Concerns

The fast-food chain will transition to 'No Antibiotics Important To Human Medicine' standard in Spring 2024, sparking debate over ethical sourcing.

Chick-fil-A announces a shift from its 'No Antibiotics Ever' policy to 'No Antibiotics Important To Human Medicine' due to supply chain concerns, starting Spring 2024.
The new policy allows for the use of animal-specific antibiotics in cases where the chicken or those around it are sick.
This change has sparked criticism and calls for boycotts from consumers and advocacy groups concerned about ethical sourcing and transparency.
The move aligns Chick-fil-A with industry trends, as other companies like Tyson Foods and Panera Bread have also revised their antibiotic policies.
Chick-fil-A remains committed to serving high-quality chicken that meets customer expectations for responsible sourcing.